Literature DB >> 6368648

Inhibition of antigen-induced bronchoconstriction by methylprednisolone succinate.

J C Delehunt, L Yerger, T Ahmed, W M Abraham.   

Abstract

We investigated whether the glucocorticoid methylprednisolone succinate mg/kg) could prevent antigen-induced bronchoconstriction in conscious sheep. Ten allergic ewes were subjected to inhalation challenge with Ascaris suum antigen, with and without methylprednisolone pretreatment, administered intravenously either 20 min or 3 hr before antigen challenge. Antigen challenge alone resulted in increased airflow resistance, pulmonary hyperinflation, and decreases in dynamic lung compliance and arterial oxygen tension. Methylprednisolone administered 20 min before antigen challenge had no effect on these antigen-induced changes. In contrast, administration of methylprednisolone 3 hr before antigen challenge effectively prevented all the responses to antigen challenge. We suggest that pretreatment with glucocorticoids can attenuate airway anaphylaxis if sufficient time is allowed between the pretreatment and the antigen challenge.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6368648     DOI: 10.1016/0091-6749(84)90358-0

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  2 in total

Review 1.  Late-phase IgE-mediated reactions.

Authors:  R F Lemanske; M Kaliner
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

2.  Immediate inhibitory effect of methylprednisolone suleptanate (U-67590A) on antigen-induced cutaneous and airway anaphylactic responses in guinea-pigs.

Authors:  M Hashimoto; Y Shinozaki; M Katori
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.